Publications (selected):

2023

Non-Neuronal Kappa Opioid Pathway Profiling in the Skin of Different Chronic Pruritus-Associated Dermatoses. Wiegmann H, Ständer S, Bobko S, Renkhold L, Lotts T, Zeidler C, Pereira M, Agelopoulos K. J Invest Dermatol. 2023 Sep;143(9):1845-1848.e2

Type 2 chronic inflammatory diseases: targets, therapies and unmet needs. Kolkhir P, Akdis CA, Akdis M, Bachert C, Bieber T, Canonica GW, Guttman-Yassky E, Metz M, Mullol J, Palomares O, Renz H, Ständer S, Zuberbier T, Maurer M. Nat Rev Drug Discov. 2023 Sep;22(9):743-767.

Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab. Deng J, Liao V, Parthasarathy V, Cornman HL, Kambala A, Kwatra MM, Ständer S, Piketty C, Chaskar P, Krishnaswamy JK, Julia V, Kwatra SG. JAMA Dermatol. 2023 Aug 9:e232609.

Clinical aspects and management of chronic itch. Zeidler C, Raap U, Witte F, Ständer S. J Allergy Clin Immunol. 2023 Jul;152(1):1-10

Indikation zur Systemtherapie bei chronischer Prurigo: Kommentierte Checkliste für die Praxis. Augustin M, Zeidler C, von Kiedrowski R, Metz M, Darsow U, Raap U, Legat FJ, Sebastian M, Weisshaar E, Ständer S. J Dtsch Dermatol Ges. 2023 Jul;21(7):822-824.

Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries. Van Beugen S, Schut C, Kupfer J, Bewley AP, Finlay AY, Gieler U, Thompson AR, Gracia-Cazaña T, Balieva F, Ferreira BR, Jemec GB, Lien L, Misery L, Marron SE, Ständer S, Zeidler C, Szabó C, Szepietowski JC, Reich A, Elyas A, Altunay IK, Legat FJ, Grivcheva-Panovska V, Romanov DV, Lvov AN, Titeca G, Sampogna F, Vulink NC, Tomás-Aragones L, Evers AWM, Dalgard FJ; European Society for Dermatology and Psychiatry (ESDaP) Study collaborators. Acta Derm Venereol. 2023 Jun 22;103:adv6485

Chronic prurigo: Insufficient disease control in spite of high healthcare usage. Pereira MP, Weisshaar E, Halvorsen JA, Wallengren J, Legat FJ, Garcovich S, Savk E, Reich A, Bozek A, Lvov A, Bobko S, Metz M, Streit M, Misery L, Brenaut E, Serra-Baldrich E, Gonçalo M, Szepietowski JC, Augustin M, Nau T, Zeidler C, Ständer S. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e808-e812

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. Yosipovitch G, Mollanazar N, Ständer S, Kwatra SG, Kim BS, Laws E, Mannent LP, Amin N, Akinlade B, Staudinger HW, Patel N, Yancopoulos GD, Weinreich DM, Wang S, Shi G, Bansal A, O'Malley JT. Nat Med. 2023 May;29(5):1180-1190.

Cost-effectiveness and Quality of Specialized and Routine Care in a German Cohort of Patients with Chronic Pruritus. Müller S, Ständer S, Naatz M, Augustin M, Steinke S. Acta Derm Venereol. 2023 Apr 21;103:adv4868

Transcriptomic, Epigenomic, and Neuroanatomic Signatures Differ in Chronic Prurigo, Atopic Dermatitis, and Brachioradial Pruritus. Agelopoulos K, Renkhold L, Wiegmann H, Dugas M, Süer A, Zeidler C, Schmelz M, Pereira MP, Ständer S. J Invest Dermatol. 2023 Feb;143(2):264-272.e3

PIEZO1 channels in cutaneous free nerve endings: novel insights into itch-scratch-mechanisms. Pereira MP, Wiegmann H, Ständer S. Signal Transduct Target Ther. 2023 Jan 2;8(1):4.